Rigel Pharmaceuticals, Inc.
RIGL
$26.55
$0.602.31%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 154.96M | 137.14M | 108.38M | 77.10M | 77.32M |
| Total Receivables | 51.76M | 45.93M | 39.91M | 41.55M | 41.62M |
| Inventory | 23.36M | 20.61M | 15.83M | 16.39M | 9.76M |
| Prepaid Expenses | 4.89M | 5.39M | 5.84M | 5.15M | 1.89M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 5.21M | 5.86M | 5.44M | 6.38M | 4.52M |
| Total Current Assets | 240.17M | 214.93M | 175.39M | 146.56M | 135.10M |
|
|
|||||
| Total Current Assets | 240.17M | 214.93M | 175.39M | 146.56M | 135.10M |
| Net Property, Plant & Equipment | 950.00K | 1.10M | 1.24M | 1.38M | 338.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 24.75M | 25.34M | 25.92M | 26.51M | 27.10M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 247.73M | 1.17M | 4.18M | 1.52M | 1.44M |
| Total Assets | 513.59M | 242.53M | 206.74M | 175.97M | 163.98M |
|
|
|||||
| Total Accounts Payable | 7.19M | 3.85M | 7.29M | 3.95M | 3.34M |
| Total Accrued Expenses | 50.46M | 48.98M | 45.18M | 41.55M | 46.33M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 30.43M | 30.36M | 22.88M | 15.27M | 7.56M |
| Total Finance Division Other Current Liabilities | 11.16M | 11.22M | 11.28M | 5.85M | 6.08M |
| Total Other Current Liabilities | 11.16M | 11.22M | 11.28M | 5.85M | 6.08M |
| Total Current Liabilities | 99.24M | 94.40M | 86.64M | 66.63M | 63.30M |
|
|
|||||
| Total Current Liabilities | 99.24M | 94.40M | 86.64M | 66.63M | 63.30M |
| Long-Term Debt | 22.48M | 29.97M | 37.45M | 84.91M | 92.39M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 395.00K | 556.00K | 714.00K | 864.00K | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | 5.00M | 5.00M |
| Total Liabilities | 122.11M | 124.93M | 124.80M | 157.41M | 160.69M |
|
|
|||||
| Common Stock & APIC | 1.41B | 1.41B | 1.40B | 1.40B | 1.39B |
| Retained Earnings | -1.02B | -1.29B | -1.32B | -1.38B | -1.39B |
| Treasury Stock & Other | 181.00K | 96.00K | 6.00K | -2.00K | 10.00K |
| Total Common Equity | 391.48M | 117.61M | 81.93M | 18.57M | 3.29M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 391.48M | 117.61M | 81.93M | 18.57M | 3.29M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 391.48M | 117.61M | 81.93M | 18.57M | 3.29M |
|
|
|||||